Last reviewed · How we verify
NCT06733116
Standardizing Reporting Practices for Isokinetic Testing: a Delphi Study
trial testing Delphi method survey in Developing a Consensus Framework to Standardize Isokinetic Testing Data Reporting in 30 participants. Not yet recruiting.
1 August 2025
Quick facts
| Lead sponsor | University Hospital, Caen |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 January 2025 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 October 2025 |
Drugs / interventions tested
- Delphi method survey
Conditions studied
- Developing a Consensus Framework to Standardize Isokinetic Testing Data Reporting — all drugs for Developing a Consensus Framework to Standardize Isokinetic Testing Data Reporting →
Sponsor
University Hospital, Caen
Who can join
18 and older, any sex, with Developing a Consensus Framework to Standardize Isokinetic Testing Data Reporting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Isokinetic testing plays a crucial role in research and clinical practice, particularly for evaluating muscle strength, functional performance, and imbalances between muscle groups in fields such as rehabilitation, sports medicine, and orthopedics. Despite its widespread use, there is no international consensus on how to standardize protocols or report results, leading to significant variability in methodologies, measurement parameters, and data presentation. This Delphi method study aims to develop a consensus framework for standardizing the reporting of isokinetic testing data, ensuring consistency and comparability in research and clinical practices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06733116
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Caen trials
Trials by the same sponsor.
- NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
- NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
- NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
- NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
- NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06733116 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
- Last refreshed: 17 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06733116.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing